148 related articles for article (PubMed ID: 18802167)
1. Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.
Ananda S; Field KM; Kosmider S; Compston D; Desai J; Lim LC; Barnett FS; Jones IT; Skinner I; Gibbs P
J Clin Oncol; 2008 Sep; 26(27):4516-7; author reply 4517-8. PubMed ID: 18802167
[No Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
3. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice.
Bouchardy C; Queneau PE; Fioretta G; Usel M; Zellweger M; Neyroud I; Raymond L; de Wolf C; Sappino AP
Br J Cancer; 2001 Nov; 85(9):1251-7. PubMed ID: 11720457
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting.
Hawfield A; Lovato J; Covington D; Kimmick G
Crit Rev Oncol Hematol; 2006 Sep; 59(3):250-5. PubMed ID: 16527489
[TBL] [Abstract][Full Text] [Related]
6. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
[TBL] [Abstract][Full Text] [Related]
8. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.
Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I
Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558
[TBL] [Abstract][Full Text] [Related]
9. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment for elderly patients with colon cancer. An observational study.
Pasetto LM; Falci C; Basso U; Gasparini G; D'Andrea M; Bonginelli P; Bajetta E; Platania M; Alabiso O; Miraglia S; Bertona E; Oniga F; Biason R; Chetrì MC; Fedele P; Massara G; Romaniello I; Negru ME; Luchena G; Giordano M; Buzzi F; Ricottao R; Sienao S; Monfardini S
Anticancer Res; 2008; 28(4C):2513-8. PubMed ID: 18751443
[TBL] [Abstract][Full Text] [Related]
11. Does reimbursement influence chemotherapy treatment for cancer patients?
Jacobson M; O'Malley AJ; Earle CC; Pakes J; Gaccione P; Newhouse JP
Health Aff (Millwood); 2006; 25(2):437-43. PubMed ID: 16522584
[TBL] [Abstract][Full Text] [Related]
12. Advances in the adjuvant treatment of colorectal cancer.
Nordman IC; Iyer S; Joshua AM; Clarke SJ
ANZ J Surg; 2006 May; 76(5):373-80. PubMed ID: 16768699
[TBL] [Abstract][Full Text] [Related]
13. Re: Completion of therapy by Medicare patients with stage III colon cancer.
Gibbs P; McLaughlin S; Skinner I; Jones I; Hayes I; Chapman M; Johns J; Lim L; Faragher I
J Natl Cancer Inst; 2006 Nov; 98(21):1582. PubMed ID: 17077360
[No Abstract] [Full Text] [Related]
14. Adjuvant therapy for colon cancer: present and perspectives.
De Dosso S; Sessa C; Saletti P
Cancer Treat Rev; 2009 Apr; 35(2):160-6. PubMed ID: 19013023
[TBL] [Abstract][Full Text] [Related]
15. Appropriate use of surveillance colonoscopy after polypectomy.
Nelson DB
Nat Clin Pract Oncol; 2005 Jan; 2(1):22-3. PubMed ID: 16264851
[No Abstract] [Full Text] [Related]
16. No clear evidence for adjuvant therapy in people with stage II colon cancer.
Wille-Jørgensen P
Cancer Treat Rev; 2005 Apr; 31(2):147-50. PubMed ID: 15847983
[No Abstract] [Full Text] [Related]
17. Perspectives, preferences, care practices, and outcomes in late-stage cancer patients: connecting the dots.
Reuben DB; Naeim A
J Clin Oncol; 2004 Dec; 22(24):4869-71. PubMed ID: 15520049
[No Abstract] [Full Text] [Related]
18. Practice patterns in colorectal cancer: a panel discussion.
Becze E
ONS Connect; 2007; 22(8 Suppl):51-2. PubMed ID: 17824564
[No Abstract] [Full Text] [Related]
19. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
20. Physician compliance with colon cancer screening.
Malik J; Sansone RA
Am J Gastroenterol; 2002 Apr; 97(4):1078-9. PubMed ID: 12003406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
